TOFACITINIB CITRATE
AJANTA PHARMA LTD · TOFACITINIB CITRATE
Open FDA's page for this record- Application number
- ANDA219542
- Sponsor name
- AJANTA PHARMA LTD
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250819
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Submission type
- SUPPL
- Submission number
- 3
- Submission status
- AP
- Submission status date
- 20261008
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission type
- ORIG
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20261019
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Submission type
- SUPPL
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20261008
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- TOFACITINIB CITRATE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- TOFACITINIB CITRATE
- Strength
- EQ 11MG BASE
- Product number
- 002
- Reference drug
- No
- Brand name
- TOFACITINIB CITRATE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- TOFACITINIB CITRATE
- Strength
- EQ 22MG BASE
- Harmonized identifiers (openFDA)
- Application number
- ANDA219542
- Brand name
- TOFACITINIB
- Generic name
- TOFACITINIB
- Manufacturer name
- Ajanta Pharma USA Inc.
- Product NDC
- 27241-270
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- TOFACITINIB CITRATE
- RxCUI
- 1741046
- SPL ID
- c2a18bfc-c6a0-482a-b3e9-df80acb9e36c
- SPL set ID
- 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed
- Package NDC
- 27241-270-30
- UNII
- O1FF4DIV0D
